Per ulteriori informazioni selezionare i riferimenti di interesse.
ASPP proteins specifically stimulate the apoptotic function of p53
MOLECULAR CELL
Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action
EUROPEAN JOURNAL OF CANCER
Isolation and characterization of an IGROV-1 human ovarian cancer cell line made resistant to Ecteinascidin-743 (ET-743)
BRITISH JOURNAL OF CANCER
Mode of action of thiocoraline, a natural marine compound with anti-tumouractivity
BRITISH JOURNAL OF CANCER
Cell cycle perturbations and apoptosis induced by isohomohalichondrin B (IHB), a natural marine compound
BRITISH JOURNAL OF CANCER
The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalenecarboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases
BLOOD
IN-VITRO SCHEDULE-DEPENDENCY OF MYELOTOXICITY AND CYTOTOXICITY OF ECTEINASCIDIN 743 (ET-743)
Annals of oncology
MODE OF ACTION OF ECTEINASCIDIN-743, A NATURAL MARINE COMPOUND WITH ANTITUMORAL ACTIVITY
Annals of oncology
THIOCORALINE, A NOVEL DNA-POLYMERASE INHIBITOR WITH A HIGHER CYTOTOXIC POTENCY AGAINST CANCER-CELLS WITH MUTATED OR INACTIVATED P53
Annals of oncology
CHARACTERIZATION OF CYCLIN B1 EXPRESSION IN HUMAN CANCER CELL-LINES BY A NEW 3-PARAMETER BRDURD CYCLIN B1/DNA ANALYSIS/
Cytometry
FLOW CYTOMETRIC ANALYSIS OF CELL-CYCLE PHASE PERTURBATIONS INDUCED BYTHIOCORALINE, A NEM MARINE-DERIVED ANTICANCER COMPOUND
European journal of histochemistry
DIFFERENCES IN CYCLIN B1 EXPRESSION IN CELLS BLOCKED IN THE G2M PHASEAFTER TREATMENT WITH ANTICANCER AGENT - NEW 3-PARAMETRIC FLOW CYTOMETRIC ANALYSIS
European journal of histochemistry
ORDER REVIEW AND RELEASE STRATEGIES IN A JOB-SHOP ENVIRONMENT - A REVIEW AND A CLASSIFICATION
International Journal of Production Research
TREATMENT WITH INHIBITORS OF POLYAMINE BIOSYNTHESIS, WHICH SELECTIVELY LOWER INTRACELLULAR SPERMINE, DOES NOT AFFECT THE ACTIVITY OF ALKYLATING-AGENTS BUT ANTAGONIZES THE CYTOTOXICITY OF DNA TOPOISOMERASE-II INHIBITORS
British Journal of Cancer